Goldman Sachs
HGEN

Goldman Sachs’s HUMANIGEN, INC. HGEN Stock Holding History

Goldman Sachs’s Portfolio HGEN Stock Details HGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-215,900
Closed -$382K – 6699
2022
Q2 		$382K Buy
215,900
+114,858
+114% +$258K ﹤0.01% 5270
2022
Q1 		$304K Sell
101,042
-120,951
-54% -$324K ﹤0.01% 5654
2021
Q4 		$826K Buy
221,993
+168,176
+312% +$984K ﹤0.01% 5012
2021
Q3 		$319K Buy
53,817
+19,067
+55% +$268K ﹤0.01% 5461
2021
Q2 		$604K Sell
34,750
-39,280
-53% -$716K ﹤0.01% 5107
2021
Q1 		$1.41M Buy
+74,030
New +$1.35M ﹤0.01% 4327

Other funds holding HGEN

GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Goldman Sachs's HGEN Position: Q3 2022 in Review

Goldman Sachs sold out of HUMANIGEN, INC. (HGEN) in Q3 2022, closing a stake of 215,900 shares — an estimated $382K sold.

Goldman Sachs first reported a position in HGEN in Q1 2021 and held it in 6 quarters. The position peaked at $1.41M in Q1 2021. 53 funds tracked by Wall St. Rank hold HGEN as of Q3 2022.

  • Goldman Sachs reported no remaining HUMANIGEN, INC. position as of Q3 2022 after selling out during the quarter.
  • Goldman Sachs sold 215,900 HUMANIGEN, INC. shares in Q3 2022, an estimated $382K.
  • Goldman Sachs first reported a position in HUMANIGEN, INC. in Q1 2021 and held it in 6 quarters.
  • Goldman Sachs's HUMANIGEN, INC. position peaked at $1.41M in Q1 2021.
  • 53 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q3 2022.

Based on Goldman Sachs's 13F filing for Q3 2022, filed 14 Nov 2022.